Login / Signup

Does Non-Adherence Increase Treatment Costs in Schizophrenia?

Mark W PenningtonPaul McCrone
Published in: PharmacoEconomics (2019)
Inference from analysis of administrative data is limited by the risk of selection bias. Inference from trials is limited by small sample sizes. The literature does not consistently support an assumption that non-adherence increases healthcare costs.
Keyphrases
  • healthcare
  • single cell
  • bipolar disorder
  • electronic health record
  • big data
  • skeletal muscle
  • insulin resistance
  • health information
  • data analysis